Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Claudia Maria Trombetta, Serena Marchi, Ilaria Manini, Giacomo Lazzeri & Emanuele Montomoli. (2019) Challenges in the development of egg-independent vaccines for influenza. Expert Review of Vaccines 18:7, pages 737-750.
Read now
Read now
Cecilia Trucchi, Chiara Paganino, Daniela Amicizia, Andrea Orsi, Valentino Tisa, Maria Francesca Piazza, Giancarlo Icardi & Filippo Ansaldi. (2019) Universal influenza virus vaccines: what needs to happen next?. Expert Opinion on Biological Therapy 19:7, pages 671-683.
Read now
Read now
E Gianchecchi, A Torelli & E Montomoli. (2019) The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity. Human Vaccines & Immunotherapeutics 15:5, pages 1021-1030.
Read now
Read now
Sandrine I. Samson, Phillip S. Leventhal, Camille Salamand, Ya Meng, Bruce T. Seet, Victoria Landolfi, David Greenberg & Rosalind Hollingsworth. (2019) Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis. Expert Review of Vaccines 18:3, pages 295-308.
Read now
Read now
David P. Greenberg, Corwin A. Robertson, H. Keipp Talbot & Michael D. Decker. (2017) Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older. Human Vaccines & Immunotherapeutics 13:9, pages 2058-2064.
Read now
Read now
Claudia Maria Trombetta & Emanuele Montomoli. (2016) Influenza immunology evaluation and correlates of protection: a focus on vaccines. Expert Review of Vaccines 15:8, pages 967-976.
Read now
Read now
Barnaby E Young, Sapna P Sadarangani & Yee Sin Leo. (2015) The avian influenza vaccine Emerflu. Why did it fail?. Expert Review of Vaccines 14:8, pages 1125-1134.
Read now
Read now
Nagendra R Hegde. (2015) Cell culture-based influenza vaccines: A necessary and indispensable investment for the future. Human Vaccines & Immunotherapeutics 11:5, pages 1223-1234.
Read now
Read now
Renée A J van Boxtel, Pauline Verdijk, Otto J de Boer, Elly van Riet, Tjeert T Mensinga & Willem Luytjes. (2015) Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial. Human Vaccines & Immunotherapeutics 11:4, pages 983-990.
Read now
Read now
Robert M Jacobson, Diane E Grill, Ann L Oberg, Pritish K Tosh, Inna G Ovsyannikova & Gregory A Poland. (2015) Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers . Human Vaccines & Immunotherapeutics 11:4, pages 961-969.
Read now
Read now
Cécile van Els, Siri Mjaaland, Lisbeth Næss, Julia Sarkadi, Eva Gonczol, Karen Smith Korsholm, Jon Hansen, Jørgen de Jonge, Gideon Kersten, Jennifer Warner, Amanda Semper, Corine Kruiswijk & Fredrik Oftung. (2014) Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics 10:7, pages 1935-1948.
Read now
Read now
Articles from other publishers (89)
Katherine V Williams, Zhu-Nan Li, Bo Zhai, John F Alcorn, Mary Patricia Nowalk, Min Z Levine, Sara S Kim, Brendan Flannery, Krissy Moehling Geffel, Amanda Jaber Merranko, Mark Collins, Michael Susick, Karen S Clarke, Richard K Zimmerman & Judith M Martin. (2023) A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in Children. Journal of the Pediatric Infectious Diseases Society.
Crossref
Crossref
Dominique E. Martin, Andreia N. Cadar, Hunter Panier, Blake L. Torrance, George A. Kuchel & Jenna M. Bartley. (2023) The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial. Immunity & Ageing 20:1.
Crossref
Crossref
Karol Szymański, Katarzyna Kondratiuk, Ewelina Hallmann, Anna Poznańska & Lidia B. Brydak. (2023) Hemagglutinin Antibodies in the Polish Population during the 2019/2020 Epidemic Season. Viruses 15:3, pages 760.
Crossref
Crossref
Gary P. Anderson, Louis B. Irving, Andrew Jarnicki, Katherine Kedzierska, Marios Koutsakos, Stephen Kent, Aeron C. Hurt, Adam K. Wheatley, Thi H.O. Nguyen, Natale Snape & John W. Upham. (2023) Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study. ERJ Open Research 9:2, pages 00641-2021.
Crossref
Crossref
Yudum Tepeli Büyüksünetçi & Ülkü Anık. (2023) Electro-Nano Diagnostic Platform Based on Antibody–Antigen Interaction: An Electrochemical Immunosensor for Influenza A Virus Detection. Biosensors 13:2, pages 176.
Crossref
Crossref
Hyun-Jung Kong, Youngwon Choi, Eun-Ah KimJun Chang. (2023) Vaccine Strategy That Enhances the Protective Efficacy of Systemic Immunization by Establishing Lung-Resident Memory CD8 T Cells Against Influenza Infection. Immune Network 23:4.
Crossref
Crossref
Stanley A. Plotkin & Peter B. Gilbert. 2023. Plotkin's Vaccines. Plotkin's Vaccines
45
51.e5
.
Ravina, Subodh, Krishna Kant Sharma & Hari Mohan. 2023. Virus-Host Interactions. Virus-Host Interactions
109
127
.
Min Z. Levine, Crystal Holiday, Yaohui Bai, Weimin Zhong, Feng Liu, Stacie Jefferson, F. Liaini Gross, Wen-pin Tzeng, Louis Fries, Gale Smith, Philippe Boutet, Damien Friel, Bruce L. Innis, Corey P. Mallett, C. Todd Davis, David E. Wentworth, Ian A. York, James Stevens, Jacqueline M. Katz & Terrence Tumpey. (2022) Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity. Vaccines 10:11, pages 1856.
Crossref
Crossref
Weimin Guo, Dayong Wu, Lijun Li, Samuel Ding & Simin Nikbin Meydani. (2022) Obesity, rather than high fat diet, exacerbates the outcome of influenza virus infection in influenza-sensitized mice. Frontiers in Nutrition 9.
Crossref
Crossref
Yudum Tepeli Büyüksünetçi & Ülkü Anık. (2022) Graphene‐Gold Hybrid Nanomaterial Based Impedimetric Immunosensor for H3N2 Influenza A Virus Detection. ChemistrySelect 7:36.
Crossref
Crossref
Fredrik Oftung, Lisbeth M. Næss, Ida Laake, Gregory Stoloff & Olga Pleguezuelos. (2022) FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay. Vaccines 10:9, pages 1528.
Crossref
Crossref
Mohamad Ammar Ayass, Wanying Cao, Jin Zhang, Jun Dai, Kevin Zhu, Trivendra Tripathi, Natalya Griko, Victor Pashkov & Lina Abi-Mosleh. (2022) Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system. PLOS ONE 17:9, pages e0274228.
Crossref
Crossref
Yorick Janssens, Jasper Joye, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels & Isabel Leroux-Roels. (2022) The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Frontiers in Immunology 13.
Crossref
Crossref
Fleur Whitlock, Pablo R. Murcia & J. Richard Newton. (2022) A Review on Equine Influenza from a Human Influenza Perspective. Viruses 14:6, pages 1312.
Crossref
Crossref
Ravina, Paramjeet Singh Gill, Jagriti Narang, Ashok Kumar & Hari Mohan. (2022) Development of amperometric biosensor based on cloned hemagglutinin gene of H1N1 (swine flu) virus. 3 Biotech 12:6.
Crossref
Crossref
José María Díez, Carolina Romero, María Cruz, Peter Vandeberg, William Keither Merritt, Edwards Pradenas, Benjamin Trinité, Julià Blanco, Bonaventura Clotet, Todd Willis & Rodrigo Gajardo. (2022) Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins. The Journal of Infectious Diseases 225:6, pages 938-946.
Crossref
Crossref
Ravina, Paramjeet Singh Gill, Ashok kumar, Jagriti Narang, Minakshi Prasad & Hari Mohan. (2022) Molecular detection of H1N1 virus by conventional reverse transcription PCR coupled with nested PCR. Sensors International 3, pages 100178.
Crossref
Crossref
Janna R. Shapiro, Huifen Li, Rosemary Morgan, Yiyin Chen, Helen Kuo, Xiaoxuan Ning, Patrick Shea, Cunjin Wu, Katherine Merport, Rayna Saldanha, Suifeng Liu, Engle Abrams, Yan Chen, Denise C. Kelly, Eileen Sheridan-Malone, Lan Wang, Scott L. Zeger, Sabra L. Klein & Sean X. Leng. (2021) Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults. npj Vaccines 6:1.
Crossref
Crossref
Mariana Rivera-Patron, María Moreno, Mariana Baz, Paulo M. Roehe, Samuel P. Cibulski & Fernando Silveira. (2021) ISCOM-like Nanoparticles Formulated with Quillaja brasiliensis Saponins Are Promising Adjuvants for Seasonal Influenza Vaccines. Vaccines 9:11, pages 1350.
Crossref
Crossref
Kristine A. Moore, Julia T. Ostrowsky, Alison M. Kraigsley, Angela J. Mehr, Joseph S. Bresee, Martin H. Friede, Bruce G. Gellin, Josephine P. Golding, Peter J. Hart, Ann Moen, Charlotte L. Weller, Michael T. Osterholm, William Ampofo, Wendy Barclay, Marco Cavaleri, Cheryl Cohen, Benjamin Cowling, Rebecca Cox, Ian Gust, Bruce Innis, Gagandeep Kang, Jacqueline Katz, Florian Krammer, Punnee Pitisuttithum, Diane Post, Larisa Rudenko, Marilda Siqueira & Jerry Weir. (2021) A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. Vaccine 39:45, pages 6573-6584.
Crossref
Crossref
Praveen Belagal, Hemanth Naick Banavath & Buddolla Viswanath. 2021. Pandemic Outbreaks in the 21st Century. Pandemic Outbreaks in the 21st Century
57
86
.
Carol D Weiss, Wei Wang, Yun Lu, Monisha Billings, Angelia Eick-Cost, Laura Couzens, Jose L Sanchez, Anthony W Hawksworth, Peter Seguin, Christopher A Myers, Richard Forshee, Maryna C Eichelberger & Michael J Cooper. (2020) Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military Recruits. Clinical Infectious Diseases 71:12, pages 3096-3102.
Crossref
Crossref
Ravina, Anita Dalal, Paramjeet Singh Gill, Jagriti Narang, Minakshi Prasad & Hari Mohan. (2020) Genosensor for rapid, sensitive, specific point-of-care detection of H1N1 influenza (swine flu). Process Biochemistry 98, pages 262-268.
Crossref
Crossref
Christopher E. Lopez & Kevin L. Legge. (2020) Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine. Vaccines 8:3, pages 434.
Crossref
Crossref
Steph Wraith, Raffael Nachbagauer, Angel Balmaseda, Daniel Stadlbauer, Sergio Ojeda, Arvind Rajabhathor, Roger Lopez, Andrea F. Guglia, Nery Sanchez, Fatima Amanat, Lionel Gresh, Guillermina Kuan, Florian Krammer & Aubree Gordon. (2020) Antibody responses to influenza A(H1N1)pdm infection. Vaccine 38:27, pages 4221-4225.
Crossref
Crossref
Ravina, Anita Dalal, Hari Mohan, Minakshi Prasad & C.S. Pundir. (2020) Detection methods for influenza A H1N1 virus with special reference to biosensors: a review. Bioscience Reports 40:2.
Crossref
Crossref
Stanley A. Plotkin. (2020) Updates on immunologic correlates of vaccine-induced protection. Vaccine 38:9, pages 2250-2257.
Crossref
Crossref
Alla A. Tarasova, Michail P. Kostinov & Julia A. Paramonova. (2020) Approaches to vaccine prophilaxis of respiratory infections in patients with diabetes mellitus in the modern epidemiological situation. Diabetes mellitus 22:5, pages 473-480.
Crossref
Crossref
Marta Sisteré-Oró, Susana Martínez-Pulgarín, David Solanes, Veljko Veljkovic, Sergi López-Serrano, Lorena Córdoba, Ivan Cordón, José M. Escribano & Ayub Darji. (2020) Conserved HA-peptides expressed along with flagellin in Trichoplusia ni larvae protects chicken against intranasal H7N1 HPAIV challenge. Vaccine 38:3, pages 416-422.
Crossref
Crossref
Maria Ganczak, Paulina Dubiel, Marzena Drozd-Dąbrowska, Ewelina Hallmann-Szelińska, Karol Szymański & Lidia B. Brydak. (2019) Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season. International Journal of Environmental Research and Public Health 16:22, pages 4489.
Crossref
Crossref
Zackery A. G. Knowlden, Katherine A. Richards, Savannah A. Moritzky & Andrea J. Sant. (2019) Peptide Epitope Hot Spots of CD4 T Cell Recognition Within Influenza Hemagglutinin During the Primary Response to Infection. Pathogens 8:4, pages 220.
Crossref
Crossref
Mark G Thompson, Min Z Levine, Silvia Bino, Danielle R Hunt, Tareq M Al-Sanouri, Eric A F Simões, Rachael M Porter, Holly M Biggs, Lionel Gresh, Artan Simaku, Illham Abu Khader, Veronica L Tallo, Jennifer K Meece, Meredith McMorrow, Edelwisa S Mercado, Sneha Joshi, Nicholas P DeGroote, Iris Hatibi, Felix Sanchez, Marilla G Lucero, Samir Faouri, Stacie N Jefferson, Numila Maliqari, Angel Balmaseda, Diozele Sanvictores, Crystal Holiday, Cristina Sciuto, Zachary Owens, Eduardo Azziz-Baumgartner & Aubree Gordon. (2019) Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study. The Lancet Child & Adolescent Health 3:11, pages 781-794.
Crossref
Crossref
Ajitanuj Rattan, Katherine A. Richards, Zackery A. G. Knowlden & Andrea J. Sant. (2019)
Protein Vaccination Directs the CD4
+
T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection
. Journal of Virology 93:20.
Crossref
Crossref
James A. Hay, Karen Laurie, Michael White & Steven Riley. (2019) Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets. PLOS Computational Biology 15:8, pages e1007294.
Crossref
Crossref
Cedric Hirzel, Victor H. Ferreira, Arnaud G. L'Huillier, Katja Hoschler, Elisa Cordero, Ajit P. Limaye, Janet A. Englund, Gail Reid, Atul Humar, Deepali Kumar, Pilar Perez‐Romero, Teresa Aydillo, Jordi Carratala, Patricia Munoz, Miguel Montejo, Francisco Lopez‐Medrano, Maria Carmen Farinas, Joan Gavalda, Asuncion Moreno, Jesus Fortun & Julian Torre‐Cisneros. (2019) Humoral response to natural influenza infection in solid organ transplant recipients. American Journal of Transplantation 19:8, pages 2318-2328.
Crossref
Crossref
Tanvi Potluri, Ashley L. Fink, Kristyn E. Sylvia, Santosh Dhakal, Meghan S. Vermillion, Landon vom Steeg, Sharvari Deshpande, Harish Narasimhan & Sabra L. Klein. (2019) Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. npj Vaccines 4:1.
Crossref
Crossref
Ravina, Hari Mohan, Paramjeet Singh Gill & Ashok Kumar. (2019) Hemagglutinin gene based biosensor for early detection of swine flu (H1N1) infection in human. International Journal of Biological Macromolecules 130, pages 720-726.
Crossref
Crossref
Stephanie Fischinger, Carolyn M. Boudreau, Audrey L. Butler, Hendrik Streeck & Galit Alter. (2018) Sex differences in vaccine-induced humoral immunity. Seminars in Immunopathology 41:2, pages 239-249.
Crossref
Crossref
Anne Conrad, Mathilde Boccard, Florent Valour, Vincent Alcazer, Aydee-Tamara Tovar Sanchez, Christian Chidiac, Frédéric Laurent, Philippe Vanhems, Gilles Salles, Karen Brengel-Pesce, Boris Meunier, Sophie Trouillet-Assant & Florence Ader. (2019) VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients. BMJ Open 9:2, pages e026093.
Crossref
Crossref
J.M. Van Emon. 2019. Comprehensive Biotechnology. Comprehensive Biotechnology
668
678
.
Erik A. Karlsson, J. Justin Milner, William D. Green, Jennifer Rebeles, Stacey Schultz-Cherry & Melinda A. Beck. 2019. Mechanisms and Manifestations of Obesity in Lung Disease. Mechanisms and Manifestations of Obesity in Lung Disease
227
259
.
Marta C. Nunes, Adriana Weinberg, Clare L. Cutland, Stephanie Jones, David Wang, Bonnie Dighero-Kemp, Min Z. Levine, Niteen Wairagkar & Shabir A. Madhi. (2018) Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women. PLOS ONE 13:12, pages e0210124.
Crossref
Crossref
Vipin Narang, Yanxia Lu, Crystal Tan, Xavier F. N. Camous, Shwe Zin Nyunt, Christophe Carre, Esther Wing Hei Mok, Glenn Wong, Sebastian Maurer-Stroh, Brian Abel, Nicolas Burdin, Michael Poidinger, Paul Anantharajah Tambyah, Nabil Bosco, Lucian Visan, Tze Pin Ng & Anis Larbi. (2018) Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure. Frontiers in Immunology 9.
Crossref
Crossref
Alexander I. Makarkov, Aakash R. Patel, Valentine Bainov & Brian J. Ward. (2018) A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable – A proof of concept study. Vaccine 36:30, pages 4485-4493.
Crossref
Crossref
Hannah Stacey, Neda Barjesteh, Jonathan Mapletoft & Matthew Miller. (2018) “Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy. Vaccines 6:2, pages 23.
Crossref
Crossref
Alain Gagnon, Enrique Acosta, Stacey Hallman, Robert Bourbeau, Lisa Y. Dillon, Nadine Ouellette, David J. D. Earn, D. Ann Herring, Kris Inwood, Joaquin Madrenas & Matthew S. Miller. (2018) Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic. mBio 9:1.
Crossref
Crossref
Stanley A. Plotkin & Peter Gilbert. 2018. Plotkin's Vaccines. Plotkin's Vaccines
35
40.e4
.
Eva van Doorn, Olga Pleguezuelos, Heng Liu, Ana Fernandez, Robin Bannister, Gregory Stoloff, Fredrik Oftung, Stephen Norley, Anke Huckriede, Henderik W. Frijlink & Eelko Hak. (2017) Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial. BMC Infectious Diseases 17:1.
Crossref
Crossref
Ram P. Kamal, Kristy Blanchfield, Jessica A. Belser, Nedzad Music, Wen-Pin Tzeng, Crystal Holiday, Ashley Burroughs, Xiangjie Sun, Taronna R. Maines, Min Z. Levine & Ian A. York. (2017) Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Journal of Virology 91:20.
Crossref
Crossref
Gale Smith, Ye Liu, David Flyer, Michael J. Massare, Bin Zhou, Nita Patel, Larry Ellingsworth, Maggie Lewis, James F. Cummings & Greg Glenn. (2017) Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes. Vaccine 35:40, pages 5366-5372.
Crossref
Crossref
Lisa M. Christian, Chloe Beverly, Amanda M. Mitchell, Erik Karlsson, Kyle Porter, Stacey Schultz-Cherry & Octavio Ramilo. (2017) Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns. Vaccine 35:39, pages 5283-5290.
Crossref
Crossref
Sarah T. C. Elliott, Nicole L. Kallewaard, Ebony Benjamin, Leslie Wachter-Rosati, Josephine M. McAuliffe, Ami Patel, Trevor R. F. Smith, Katherine Schultheis, Daniel H. Park, Seleeke Flingai, Megan C. Wise, Janess Mendoza, Stephanie Ramos, Kate E. Broderick, Jian Yan, Laurent M. Humeau, Niranjan Y. Sardesai, Kar Muthumani, Qing Zhu & David B. Weiner. (2017) DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections. npj Vaccines 2:1.
Crossref
Crossref
Xin-Xing Gu, Stanley A. Plotkin, Kathryn M. Edwards, Alessandro Sette, Kingston H. G. Mills, Ofer Levy, Andrea J. Sant, Annie Mo, William Alexander, Kristina T. Lu & Christopher E. Taylor. (2017) Waning Immunity and Microbial Vaccines—Workshop of the National Institute of Allergy and Infectious Diseases. Clinical and Vaccine Immunology 24:7.
Crossref
Crossref
Garrett Wilson, Zhiping Ye, Hang Xie, Steven Vahl, Erica Dawson & Kathy Rowlen. (2017) Automated interpretation of influenza hemagglutination inhibition (HAI) assays: Is plate tilting necessary?. PLOS ONE 12:6, pages e0179939.
Crossref
Crossref
Victoria M. W. Gould, James N. Francis, Katie J. Anderson, Bertrand Georges, Alethea V. Cope & John S. Tregoning. (2017) Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre. Frontiers in Microbiology 8.
Crossref
Crossref
Jeremy C. Jones, Bindumadhav M. Marathe, Peter Vogel, Rodolfo Gasser, Isabel Najera & Elena A. Govorkova. (2017) The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses. Antimicrobial Agents and Chemotherapy 61:5.
Crossref
Crossref
Neal Van Hoeven, Christopher B. Fox, Brian Granger, Tara Evers, Sharvari W. Joshi, Ghislain I. Nana, Sarah C. Evans, Susan Lin, Hong Liang, Li Liang, Rie Nakajima, Philip L. Felgner, Richard A. Bowen, Nicole Marlenee, Airn Hartwig, Susan L. Baldwin, Rhea N. Coler, Mark Tomai, James Elvecrog, Steven G. Reed & Darrick Carter. (2017) A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines. Scientific Reports 7:1.
Crossref
Crossref
Eva van Doorn, Heng Liu, Tamar Ben-Yedidia, Shimon Hassin, Ildiko Visontai, Stephen Norley, Henderik W. Frijlink & Eelko Hak. (2017) Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine. Medicine 96:11, pages e6339.
Crossref
Crossref
Brian J. Lenny, Stephanie Sonnberg, Angela F. Danner, Kimberly Friedman, Richard J. Webby, Robert G. Webster & Jeremy C. Jones. (2017) Evaluation of multivalent H2 influenza pandemic vaccines in mice. Vaccine 35:10, pages 1455-1463.
Crossref
Crossref
Li Wang, Timothy Z. Chang, Yuan He, Jong R. Kim, Shelly Wang, Teena Mohan, Zachary Berman, S. Mark Tompkins, Ralph A. Tripp, Richard W. Compans, Julie A. Champion & Bao-Zhong Wang. (2017) Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity. Nanomedicine: Nanotechnology, Biology and Medicine 13:1, pages 253-262.
Crossref
Crossref
Jessica A. Belser & Terrence M. Tumpey. 2016. Animal Influenza. Animal Influenza
594
617
.
Min Z. Levine, Judith M. Martin, F. Liaini Gross, Stacie Jefferson, Kelly Stefano Cole, Crystal Ann Archibald, Mary Patricia Nowalk, Michael Susick, Krissy Moehling, Sarah Spencer, Jessie R. Chung, Brendan Flannery & Richard K. Zimmerman. (2016) Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination. Clinical and Vaccine Immunology 23:10, pages 831-839.
Crossref
Crossref
Wagner Quintilio, Fábio Alessandro de Freitas, Dunia Rodriguez, Flavia Saldanha Kubrusly, Dimitri Yourtov, Cosue Miyaki, Luciana Cezar de Cerqueira Leite & Isaias Raw. (2016) Vitamins as influenza vaccine adjuvant components. Archives of Virology 161:10, pages 2787-2795.
Crossref
Crossref
Erik A. Karlsson, Tomer Hertz, Cydney Johnson, Andrew Mehle, Florian Krammer & Stacey Schultz-Cherry. (2016) Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination. mBio 7:4.
Crossref
Crossref
Laura Lambert, Ekaterina Kinnear, Jacqueline U. McDonald, Gunnveig Grodeland, Bjarne Bogen, Elisabeth Stubsrud, Mona M. Lindeberg, Agnete Brunsvik Fredriksen & John S. Tregoning. (2016) DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease. Frontiers in Immunology 7.
Crossref
Crossref
Mary Zacour, Brian J. Ward, Angela Brewer, Patrick Tang, Guy Boivin, Yan Li, Michelle Warhuus, Shelly A. McNeil, Jason J. LeBlanc & Todd F. Hatchette. (2016) Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories. Clinical and Vaccine Immunology 23:3, pages 236-242.
Crossref
Crossref
Andrew J. Dunning, Carlos A. DiazGranados, Timothy Voloshen, Branda Hu, Victoria A. Landolfi & H. Keipp Talbot. (2016) Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial. Clinical and Vaccine Immunology 23:3, pages 228-235.
Crossref
Crossref
Shin-ichi Tamura, Akira Ainai, Tadaki Suzuki, Takeshi Kurata & Hideki Hasegawa. (2016) Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?. Japanese Journal of Infectious Diseases 69:3, pages 165-179.
Crossref
Crossref
Michael J. Carter, Christoph J. Blomke & Andrew J. Pollard. 2016. The Vaccine Book. The Vaccine Book
121
149
.
Cornelius Remschmidt, Ole Wichmann & Thomas Harder. (2015) Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Medicine 13:1.
Crossref
Crossref
O. Amen, S.V. Vemula, J. Zhao, R. Ibrahim, A. Hussein, I.K. Hewlett, S. Moussa & S.K. Mittal. (2015) Identification and characterization of a highly pathogenic H5N1 avian influenza A virus during an outbreak in vaccinated chickens in Egypt. Virus Research 210, pages 337-343.
Crossref
Crossref
John Jay Treanor. (2015) Prospects for Broadly Protective Influenza Vaccines. American Journal of Preventive Medicine 49:6, pages S355-S363.
Crossref
Crossref
Jason R. Wilson, Zhu Guo, Wen-Pin Tzeng, Rebecca J. Garten, Xu Xiyan, Elisabeth G. Blanchard, Kristy Blanchfield, James Stevens, Jacqueline M. Katz & Ian A. York. (2015) Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus. Virology 485, pages 252-262.
Crossref
Crossref
John Jay Treanor. (2015) Prospects for broadly protective influenza vaccines. Vaccine 33, pages D39-D45.
Crossref
Crossref
Arnold S. Monto, Joshua G. Petrie, Rachel T. Cross, Emileigh Johnson, Merry Liu, Weimin Zhong, Min Levine, Jacqueline M. Katz & Suzanne E. Ohmit. (2015) Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. Journal of Infectious Diseases 212:8, pages 1191-1199.
Crossref
Crossref
Andres F Gutierrez & Hana El Sahly. (2015) Recombinant hemagglutinin protein vaccine: a new option in immunization against influenza. Future Virology 10:9, pages 1057-1067.
Crossref
Crossref
David Liebowitz, Jonathan D Lindbloom, Jennifer R Brandl, Shaily J Garg & Sean N Tucker. (2015) High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial. The Lancet Infectious Diseases 15:9, pages 1041-1048.
Crossref
Crossref
B Blümel, B Schweiger, M Dehnert, S Buda, A Reuss, I Czogiel, P Kamtsiuris, M Schlaud, C Poethko-Müller, M Thamm & W Haas. (2015) Age-related prevalence of cross-reactive antibodies against influenza A(H3N2) variant virus, Germany, 2003 to 2010. Eurosurveillance 20:32.
Crossref
Crossref
Gunnveig Grødeland, Even Fossum & Bjarne Bogen. (2015) Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines. Frontiers in Immunology 6.
Crossref
Crossref
Richard B. Kennedy, Pritish K. Tosh, Krista M. Goergen, Diane E. Grill, Ann L. Oberg & Gregory A. Poland. (2015) Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults. Vaccine 33:31, pages 3682-3688.
Crossref
Crossref
Francesca Ferrara, Eleonora Molesti & Nigel Temperton. (2015) The application of pseudotypes to influenza pandemic preparedness. Future Virology 10:6, pages 731-749.
Crossref
Crossref
Iana H. Haralambieva, Scott D. Painter, Richard B. Kennedy, Inna G. Ovsyannikova, Nathaniel D. Lambert, Krista M. Goergen, Ann L. Oberg & Gregory A. Poland. (2015) The Impact of Immunosenescence on Humoral Immune Response Variation after Influenza A/H1N1 Vaccination in Older Subjects. PLOS ONE 10:3, pages e0122282.
Crossref
Crossref
Lynda Coughlan, Caitlin Mullarkey & Sarah Gilbert. (2015) Adenoviral vectors as novel vaccines for influenza. Journal of Pharmacy and Pharmacology 67:3, pages 382-399.
Crossref
Crossref
Cornelius Remschmidt, Ole Wichmann & Thomas Harder. (2014) Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety. BMC Medicine 12:1.
Crossref
Crossref
Mary Dawn T. CoMasanori TerajimaStephen J. ThomasRichard G. JarmanKamonthip RungrojcharoenkitStefan FernandezIn-Kyu YoonDarunee BuddhariJohn CruzFrancis A. Ennis. (2014) Relationship of Preexisting Influenza Hemagglutination Inhibition, Complement-Dependent Lytic, and Antibody-Dependent Cellular Cytotoxicity Antibodies to the Development of Clinical Illness in a Prospective Study of A(H1N1)pdm09 Influenza in Children. Viral Immunology 27:8, pages 375-382.
Crossref
Crossref
Scott D. PainterIana H. HaralambievaInna G. OvsyannikovaDiane E. GrillGregory A. Poland. (2014) Detection of Influenza A/H1N1-Specific Human IgG-Secreting B Cells in Older Adults by ELISPOT Assay. Viral Immunology 27:2, pages 32-38.
Crossref
Crossref
Annett Hessel, Helga Savidis-Dacho, Sogue Coulibaly, Daniel Portsmouth, Thomas R. Kreil, Brian A. Crowe, Michael G. Schwendinger, Andreas Pilz, P. Noel Barrett, Falko G. Falkner & Birgit Schäfer. (2014) MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses. PLoS ONE 9:2, pages e88340.
Crossref
Crossref
Elling Ulvestad. (2014) Re: Jakten på det utenomjordiske. Tidsskrift for Den norske legeforening 134:18, pages 1729-1729.
Crossref
Crossref